[TNXP] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
12-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 81.96%
YoY- 49.19%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 2,822 3,989 0 0 0 0 0 -
PBT -14,213 -27,975 -28,981 -18,528 -11,990 -7,838 -5,479 17.20%
Tax 0 -1,216 0 0 0 -5 0 -
NP -14,213 -27,975 -28,981 -18,528 -11,990 -7,838 -5,479 17.20%
Tax Rate - - - - - - - -
Total Cost 17,035 31,964 28,981 18,528 11,990 7,838 5,479 20.79%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -503.65 -701.30 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.23 -58.40 -4.24 -319.96 -603.27 0.00 0.00 -
EPS Diluted -0.23 -58.40 -4.24 -319.96 -603.27 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.